In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tris Buffer Drug Master File in Korea (Tris Buffer KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tris Buffer. The MFDS reviews the Tris Buffer KDMF as part of the drug registration process and uses the information provided in the Tris Buffer KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tris Buffer KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tris Buffer API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tris Buffer suppliers with KDMF on PharmaCompass.